Mr. Flickinger has held sales roles at Medtronic, NuVasive and Surgalign.
“As an ever-greater number of spine procedures transition to the outpatient setting, we are among the first to focus our cutting-edge techniques and technologies for the ASC ecosystem to lead in improving less invasive care for patients,” Mr. Flickinger said in a Sept. 27 press release. “I’m looking forward to bringing the leadership and commercial expertise required for these therapies to reach their full potential.”
